Nano-silver Wound Dressing Cost Reduction via Wet Impregnation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

The high manufacturing cost of silver pretreated activated charcoal cloth for wound dressings, along with issues of blood leaking due to capillary action in existing products, limits the effectiveness and affordability of bactericidal and hemostatic wound dressings.

Innovation Solution

A nano-silver wound dressing comprising a skin contact layer, a disinfected antitoxic layer made from activated charcoal cloth impregnated with nanocrystalline silver, a blood absorbing and styptic layer using Superabsorbent Polymer (SAP), and an elastic bandage, where the activated charcoal cloth is treated using a wet chemical method instead of a heating process, reducing production costs and improving blood staunching.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If activated charcoal cloth is treated by heating process with silver, then antitoxic and disinfected effects are achieved, but manufacturing cost becomes very high

Engineering Contradiction:
Improveantitoxic and disinfected effectsVSAvoidmanufacturing cost
Core Design Contradiction:
ReliabilityVSEase of manufacture

Solution Approach 1:

The patent changes the treatment parameter from high-temperature heating process to wet chemical impregnation method. The activated charcoal cloth is impregnated with silver nitrate solution and then dried at low temperature (60-80°C), avoiding the expensive high-temperature heating process while still achieving effective silver distribution and antimicrobial properties

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent replaces the thermal field (heating process) with a chemical field (wet impregnation method). Instead of using high-temperature heating to deposit silver, the invention uses chemical impregnation with silver nitrate solution followed by low-temperature drying, substituting a complex thermal-mechanical process with a simpler chemical-wet process

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

2Quantity of substance

If absorbent cotton is used in wound dressing, then blood absorption is achieved, but capillary action causes blood leaking

Engineering Contradiction:
Improveblood absorptionVSAvoidblood leaking
Core Design Contradiction:
Quantity of substanceVSObject-generated harmful factors

Solution Approach 1:

The patent uses Superabsorbent Polymer (SAP) with controlled pore structure instead of traditional absorbent cotton. The SAP particles have a porous gel structure that absorbs blood through capillary forces within the polymer matrix, but the gelified state prevents blood from leaking outward, effectively solving the blood leaking problem while maintaining high absorption capacity

Inventive Principle:
Principle #31Porous materials

Solution Approach 2:

The patent creates a composite structure by combining SAP particles with a mesh fabric or nonwoven material. This composite structure provides both the blood absorption capability of SAP and the structural integrity to contain the absorbed blood, preventing leakage while maintaining quantitative absorption

Inventive Principle:
Principle #40Composite materials

3Reliability

If nanocrystalline silver is impregnated in activated charcoal cloth, then bactericidal effect is enhanced, but manufacturing complexity increases

Engineering Contradiction:
Improvebactericidal effectVSAvoidmanufacturing complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent segments the manufacturing process into distinct sequential steps: (1) impregnation of activated charcoal cloth with silver nitrate solution, (2) drying at low temperature, and (3) optional reduction treatment. This segmentation makes the complex nanocrystalline silver impregnation process manageable and suitable for industrial production

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent uses silver nitrate solution as an intermediary medium to deposit nanocrystalline silver onto the activated charcoal cloth. The silver nitrate solution serves as a carrier that evenly distributes silver ions throughout the fabric, which are then reduced to nanocrystalline form during drying or subsequent treatment, simplifying the direct deposition of nanocrystalline silver

Inventive Principle:
Principle #24Intermediary (Mediator)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The nano-silver wound dressing provides effective bactericidal and antitoxic functions, reduces manufacturing costs, and enhances blood staunching capabilities by using SAP to prevent blood leaking, with adjustable nanocrystalline silver content for prolonged antimicrobial activity and comfortable skin contact.

Implementation Method 1

Nanocrystalline silver results in a very large specific surface area for the release of ionic silver

Methodology Applied
Scientific EffectSurface area effect: Surface Tension

Implementation Method 2

due to capillary action of the absorbent cotton

Methodology Applied
Scientific EffectCapillary action: Capillary Action

Data Source

PatentUS7462753B2Nano-silver wound dressing
Publication Date: 2008.12.09 NAT CHUNG SHAN INST SCI & TECH
  • US7462753B2 patent drawing
  • US7462753B2 patent drawing

AI summary

A nano-silver wound dressing consisting of a skin contact layer made from hydrophilic cloth and directly contacting a wound on the surface of the skin, a disinfecting (or bactericidal) antitoxic layer made from activated charcoal cloth impregnated with nanocrystalline silver, a blood absorbing and styptic layer made from a superabsorbent polymer non-woven cloth, an isolation layer made from a composite fabric with a pore size of less than 5 μm, and an elastic bandage for fixing a main body on the site of wound. Edges of the isolation layer and the skin contact layer are integrated to form a main body while the disinfecting (or bactericidal) antitoxic layer as well as the blood absorbing and styptic layer are separated from each other and both enclosed inside the main body.